Table 4. Cox proportional hazard analysis of the 13 common DEGs for DFS and OS among patients with ovarian serous cystadenocarcinoma.
| Variable | PHA Test* | HR | P | 95%CI_L | 95%CI_H |
|---|---|---|---|---|---|
| DFS | |||||
| SIAE | 0.7022 | 1.1439 | 0.0354† | 1.0092 | 1.2965 |
| ICAM1 | 0.9702 | 1.2007 | 0.0361† | 1.0119 | 1.4247 |
| EIF4E2 | 0.7475 | 1.2159 | 0.0707 | 0.9837 | 1.5030 |
| RAB32 | 0.1007 | 0.7993 | 0.0586 | 0.6336 | 1.0082 |
| FN1 | 0.4617 | 0.7808 | 0.0158† | 0.6387 | 0.9547 |
| FGF7 | 0.3707 | 1.4987 | 0.0001† | 1.2204 | 1.8404 |
| OS | |||||
| AGE | 0.8117 | 1.0325 | 0.0008† | 1.0134 | 1.0520 |
| FGF7 | 0.1797 | 1.4019 | 0.0129† | 1.0741 | 1.8298 |
| PDGFRA | 0.2893 | 0.5232 | 0.0052† | 0.3321 | 0.8243 |
Abbreviations: DFS, disease-free survival; OS, overall survival; PHA test, proportional hazards assumption test; HR, hazard ratio.
*
!PHA test P < 0.05 violates the hazards assumption.
†
Significant.